Abstract
Purpose: The present study aimed to investigate the antitumor activity and hepatoprotective effect of the MTC, when combined with CHAM oil nanoemulsion (NE), (CHAM-MTC) on the tumor growth.
Materials/Methods: The in vitro study assessed the antineoplastic effect of CHAM-MTC on the MCF-7 breast cancer cells while the in vivo therapeutic effectiveness and toxicities of CHAM-MTC were evaluated in Ehrlich Ascites Carcinoma (EAC) bearing mice. One hundred female Swiss albino mice, divided equally into non-EAC group (negative control), untreated EAC group (positive control) and three EAC groups received once intraperitoneal injection of 0.2ml CHAM-NE, 0.2ml Normal Saline (NS) contained MTC (1mg/kg) and 0.2ml CHAM-NE mixed with MTC (1mg/kg), respectively.
Results: The in vitro results indicated that CHAM-NE could potentiate the effect of MTC in sub-effective concentrations since the half-maximal inhibitory concentration (IC50) was reduced by a factor of 21.94 when compared to the MTC-NS. The in vivo study revealed that mice treated with CHAM-MTC showed a significant increase in the median survival time (MST= 37 days) when compared to the MTC-NS treated group (MST= 29.50 days). In addition, CHAM-MTC showed protective ability against the oxidative stress and hepatic damage induced by EAC and MTC treatment.
Conclusion: The combination of MTC with CHAM-NE could be valuable in enhancing the therapeutic efficacy of MTC against EAC and in eliminating MTC-induced hepatotoxicity.
Keywords: Hepatotoxicity, oxidative stress, antioxidants, nanoemulsion, essential oils, mitomycin C.
Graphical Abstract
[1]
Gad, S.E. Mitomycin C.In Encyclopedia of Toxicology (Third Edition),; Wexler, P., Ed.; Academic Press: Oxford, 2014, pp. 354-356.
[3]
Rjiba-Touati, K.; Ayed-Boussema, I.; Belarbia, A.; Mokni, M.; Achour, A.; Bacha, H.; Abid, S. Role of recombinant human erythropoietin against mitomycin C-induced cardiac, hepatic and renal dysfunction in Wistar rats. Hum. Exp. Toxicol., 2015, 34(5), 468-478.
[4]
Pirnia, F.; Schneider, E.; Betticher, D.; Borner, M. Mitomycin C induces apoptosis and caspase-8 and-9 processing through a caspase-3 and Fas-independent pathway. Cell Death Differ., 2002, 9(9), 905.
[5]
Boamah, E.K.; White, D.E.; Talbott, K.E.; Arva, N.C.; Berman, D.; Tomasz, M.; Bargonetti, J. Mitomycin-DNA adducts induce p53-dependent and p53-independent cell death pathways. ACS Chem. Biol., 2007, 2(6), 399-407.
[6]
Tomasz, M.; Mitomycin, C. Small, fast and deadly (but very selective). Chem. Biol., 1995, 2(9), 575-579.
[7]
Emanuel’, N.; Bogdanov, G.; Orlov, V. Free-radical mechanisms in the cytotoxic action of antitumour antibiotics. Russ. Chem. Rev., 1984, 53(12), 1121-1138.
[8]
Li, F.; Xu, J.; Zhou, J.; Zhao, L.; Sheng, J.; Sun, G.; Hu, Q. Inhibition of mitomycin C-induced chromosomal aberrations by micrometer powder of selenium-enriched green tea in mice spermatocytes. Mutat. Res. Genet. Toxicol. Environ. Mutagen., 2009, 675(1), 11-16.
[9]
Maatouk, M.; Mustapha, N.; Mokdad-Bzeouich, I.; Chaaban, H.; Ioannou, I.; Ghedira, K.; Ghoul, M.; Chekir-Ghedira, L. Heated naringin mitigate the genotoxicity effect of Mitomycin C in BALB/c mice through enhancing the antioxidant status. Biomed. Pharmacother., 2018, 97, 1417-1423.
[10]
Wang, Y.; Gray, J.P.; Mishin, V.; Heck, D.E.; Laskin, D.L.; Laskin, J.D. Distinct roles of cytochrome P450 reductase in mitomycin C redox cycling and cytotoxicity. Mol. Cancer Ther., 2010, 9(6), 1852-1863.
[11]
Marinelli, A.; de Brauw, L.M.; Beerman, H.; Keizer, H.J.; van Bockel, J.H.; Tjaden, U.R.; van de Velde, C.J. Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver. Jpn. J. Clin. Oncol., 1996, 26(5), 341-350.
[12]
Verweij, J.; Stoter, G. Severe side effects of the cytotoxic drug mitomycin-C. Neth. J. Med., 1987, 30, 43-50.
[13]
Castañeda, F.; Kinne, R.K. Effects of doxorubicin, mitomycin C, and ethanol on Hep-G2 cells in vitro. J. Cancer Res. Clin. Oncol., 1999, 125(1), 1-8.
[14]
Sturgill, M.G.; Lambert, G.H. Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function. Clin. Chem., 1997, 43(8), 1512-1526.
[15]
Lazarus, H.M.; Gottfried, M.R.; Herzig, R.H.; Phillips, G.L.; Weiner, R.S.; Sarna, G.P.; Fay, J.; Wolff, S.N.; Sudilovsky, O.; Gale, R.P. Veno‐occlusive disease of the liver after high‐dose mitomycin C therapy and autologous bone marrow transplantation. Cancer, 1982, 49(9), 1789-1795.
[16]
Gautam, N.; Mantha, A.K.; Mittal, S. Essential oils and their constituents as anticancer agents: A mechanistic view. BioMed Res. Int., 2014, 2014, 23.
[17]
Asbahani, A.E.; Miladi, K.; Badri, W.; Sala, M.; Addi, E.H.A.; Casabianca, H.; Mousadik, A.E.; Hartmann, D.; Jilale, A.; Renaud, F.N.R.; Elaissari, A. Essential oils: From extraction to encapsulation. Int. J. Pharm., 2015, 483(1), 220-243.
[18]
Monge-Fuentes, V.; Muehlmann, L.A.; Longo, J.P.F.; Silva, J.R.; Fascineli, M.L.; de Souza, P.; Faria, F.; Degterev, I.A.; Rodriguez, A.; Carneiro, F.P. Photodynamic therapy mediated by acai oil (Euterpe oleracea Martius) in nanoemulsion: A potential treatment for melanoma. J. Photochem. Photobiol. B, 2017, 166, 301-310.
[19]
Mostafa, D.M.; Kassem, A.A.; Asfour, M.H.; Al Okbi, S.Y.; Mohamed, D.A.; Hamed, T.E-S. Transdermal cumin essential oil nanoemulsions with potent antioxidant and hepatoprotective activities: In vitro and in vivo evaluation. J. Mol. Liq., 2015, 212, 6-15.
[20]
Periasamy, V.S.; Athinarayanan, J.; Alshatwi, A.A. Anticancer activity of an ultrasonic nanoemulsion formulation of Nigella sativa L. essential oil on human breast cancer cells. Ultrason. Sonochem., 2016, 31, 449-455.
[21]
Choi, M-J.; Soottitantawat, A.; Nuchuchua, O.; Min, S-G.; Ruktanonchai, U. Physical and light oxidative properties of eugenol encapsulated by molecular inclusion and emulsion-diffusion method. Food Res. Int., 2009, 42(1), 148-156.
[22]
Wei, A.; Shibamoto, T. Antioxidant/lipoxygenase inhibitory activities and chemical compositions of selected essential oils. J. Agric. Food Chem., 2010, 58(12), 7218-7225.
[23]
Roby, M.H.H.; Sarhan, M.A.; Selim, K.A-H.; Khalel, K.I. Antioxidant and antimicrobial activities of essential oil and extracts of fennel (Foeniculum vulgare L.) and chamomile (Matricaria chamomilla L.). Ind. Crops Prod., 2013, 44, 437-445.
[24]
Rekka, E.A.; Kourounakis, A.P.; Kourounakis, P.N. Investigation of the effect of chamazulene on lipid peroxidation and free radical processes. Res. Commun. Mol. Pathol. Pharmacol., 1996, 92(3), 361-364.
[25]
Wei, A.; Shibamoto, T. Antioxidant activities and volatile constituents of various essential oils. J. Agric. Food Chem., 2007, 55(5), 1737-1742.
[26]
Bhaskaran, N.; Shukla, S.; Srivastava, J.K.; Gupta, S. Chamomile: An anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity. Int. J. Mol. Med., 2010, 26(6), 935-940.
[27]
Srivastava, J.K.; Pandey, M.; Gupta, S. Chamomile, a novel and selective COX-2 inhibitor with anti-inflammatory activity. Life Sci., 2009, 85(19-20), 663-669.
[28]
Fabian, D.; Juhás, Š.; Bukovská, A.; Bujňáková, D.; Grešáková, Ľ.; Koppel, J. Anti-inflammatory effects of chamomile essential oil in mice. Slovak J. Anim. Sci., 2011, 44, 111-116.
[29]
Srivastava, J.K.; Gupta, S. Antiproliferative and apoptotic effects of chamomile extract in various human cancer cells. J. Agric. Food Chem., 2007, 55(23), 9470-9478.
[30]
Salem, M.L.; Khamis, A.A-H.; Mostafa, A-H.A-H.; Ali, E.M. Antitumor potential of some selective medicinal plants on experimental tumor ascites. J. Investig. Biochem., 2017, 6, 28-36.
[31]
Alkhatib, M.H.; Al-Otaibi, W.A.; Wali, A.N. Antineoplastic activity of mitomycin C formulated in nanoemulsions-based essential oils on HeLa cervical cancer cells. Chem. Biol. Interact., 2018, 291, 72-80.
[32]
Bilia, A.R.; Piazzini, V.; Guccione, C.; Risaliti, L.; Asprea, M.; Capecchi, G.; Bergonzi, M.C. Improving on nature: the role of nanomedicine in the development of clinical natural drugs. Planta Med., 2017, 83(05), 366-381.
[33]
Council, N.R. Guide for the Care and Use of Laboratory Animals; National Academies Press, 2010.
[34]
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1983, 65(1), 55-63.
[35]
Khatune, N.A.; Islam, M.E.; Rahman, M.A.A.; Mosaddik, M.A.; Haque, M.E. In vivo cytotoxic evaluation of new benzofuran derivative isolated from Nyctanthes arbor-tristis L. on Ehrlich Ascite Carcinoma cells (EAC) in mice. J. Med. Sci., 2003, 3(2), 169-173.
[36]
Devbhuti, D.; Gupta, J.; Devbhuti, P. Studies on antitumor activity of Bryophyllum calycinum Salisb. against Ehrlich ascites carcinoma in Swiss albino mice. J. Pharm. Sci. Technol., 2012, 2(1), 31-33.
[37]
Regan, R.D.; Fenyk-Melody, J.E.; Tran, S.M.; Chen, G.; Stocking, K.L. Comparison of submental blood collection with the retroorbital and submandibular methods in mice (Mus musculus). J. Am. Assoc. Lab. Anim. Sci., 2016, 55(5), 570-576.
[38]
Gupta, M.; Mazumder, U.K.; Kumar, R.S.; Kumar, T.S. Antitumor activity and antioxidant role of Bauhinia racemosa against Ehrlich ascites carcinoma in Swiss albino mice. Acta Pharmacol. Sin., 2004, 25, 1070-1076.
[39]
Anon, I. Optimized standard method for quantitative determination of alkaline phosphatase. Biochemistry, 1970, 8, 658.
[40]
Kei, S. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin. Chim. Acta, 1978, 90(1), 37-43.
[42]
Nishikimi, M.; Rao, N.A.; Yagi, K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commun., 1972, 46(2), 849-854.
[44]
Levring, T.B.; Kongsbak, M.; Rode, A.K.O.; Woetmann, A.; Ødum, N.; Bonefeld, C.M.; Geisler, C. Human CD4+ T cells require exogenous cystine for glutathione and DNA synthesis. Oncotarget, 2015, 6(26), 21853-21864.
[45]
Boufadi, Y.M.; Van Antwerpen, P.; Chikh Alard, I.; Nève, J.; Djennas, N.; Riazi, A.; Soubhye, J. Antioxidant effects and bioavailability evaluation of propolis extract and its content of pure polyphenols. J. Food Biochem., 2018, 42(1)e12434
[46]
Fischer, A.H.; Jacobson, K.A.; Rose, J.; Zeller, R. Hematoxylin
and eosin staining of tissue and cell sections. CSH Protoc., 2008, 2008(5)pdb. prot4986
[47]
Al-Otaibi, W.A.; Alkhatib, M.H.; Wali, A.N. Cytotoxicity and apoptosis enhancement in breast and cervical cancer cells upon coadministration of mitomycin C and essential oils in nanoemulsion formulations. Biomed. Pharmacother., 2018, 106, 946-955.
[48]
Gabizon, A.A.; Tzemach, D.; Horowitz, A.T.; Shmeeda, H.; Yeh, J.; Zalipsky, S. Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes. Clin. Cancer Res., 2006, 12(6), 1913-1920.
[49]
Zhou, Q.M.; Zhang, H.; Lu, Y.Y.; Wang, X.F.; Su, S.B. Curcumin reduced the side effects of mitomycin C by inhibiting GRP58‐mediated DNA cross‐linking in MCF‐7 breast cancer xenografts. Cancer Sci., 2009, 100(11), 2040-2045.
[50]
Navarrete, A.; Armitage, E.G.; Musteanu, M.; García, A.; Mastrangelo, A.; Bujak, R.; López-Casas, P.P.; Hidalgo, M.; Barbas, C. Metabolomic evaluation of Mitomycin C and rapamycin in a personalized treatment of pancreatic cancer. Pharmacol. Res., 2014, 2(6), 12.
[51]
Hoek-van den Hil, E.F.; Schothorst, E.M.; Stelt, I.; Swarts, H.J.; Vliet, M.; Amolo, T.; Vervoort, J.J.; Venema, D.; Hollman, P.C.; Rietjens, I.M. Direct comparison of metabolic health effects of the flavonoids quercetin, hesperetin, epicatechin, apigenin and anthocyanins in high-fat-diet-fed mice. Genes Nutr., 2015, 10(4), 23.
[52]
Jacob, L.; Latha, M. Anticancer activity of Clitoria ternatea linn. against Dalton’s lymphoma. J. Pharmacogn. Phytochem., 2012, 4(4), 207-212.
[53]
Rioja, A.; Pizzey, A.R.; Marson, C.M.; Thomas, N.S.B. Preferential induction of apoptosis of leukaemic cells by farnesol. FEBS Lett., 2000, 467(2-3), 291-295.
[54]
Adany, I.; Yazlovitskaya, E.M.; Haug, J.S.; Voziyan, P.A.; Melnykovych, G. Differences in sensitivity to farnesol toxicity between neoplastically-and non-neoplastically-derived cells in culture. Cancer Lett., 1994, 79(2), 175-179.
[55]
Yazlovitskaya, E.M.; Melnykovych, G. Selective farnesol toxicity and translocation of protein kinase C in neoplastic HeLa-S3K and non-neoplastic CF-3 cells. Cancer Lett., 1995, 88(2), 179-183.
[56]
Horn, T.L.; Long, L.; Cwik, M.J.; Morrissey, R.L.; Kapetanovic, I.M.; McCormick, D.L. Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol. Chem. Biol. Interact., 2005, 152(2-3), 79-99.
[57]
Duncan, R.E.; Archer, M.C. Farnesol decreases serum triglycerides in rats: identification of mechanisms including up-regulation of PPARα and down-regulation of fatty acid synthase in hepatocytes. Lipids, 2008, 43(7), 619-627.
[58]
Joo, J.H.; Jetten, A.M. Molecular mechanisms involved in farnesol-induced apoptosis. Cancer Lett., 2010, 287(2), 123-135.
[59]
Salem, F.S.; Badr, M.; Neamat-Allah, A. Biochemical and
pathological studies on the effects of levamisole and chlorambucil
on Ehrlich ascites carcinoma-bearing mice. Vet. Ital., 2011, 47(1)89e95
[60]
Badr, O.M.; Sakr, S.A.; Abd-Eltawab, H.M. Ameliorative effect of ginger extract against pathological alterations induced in mice bearing solid tumors. JBAAR, 2016, 2(3), 185-196.
[61]
Patra, S.; Muthuraman, M.S.; Prabhu, A.; Priyadharshini, R.R.; Parthiban, S. Evaluation of antitumor and antioxidant activity of Sargassum tenerrimum against Ehrlich ascites carcinoma in mice. Asian Pac. J. Cancer Prev., 2015, 16(3), 915-921.
[62]
Soliman, A.M.; Fahmy, S.R.; El-Abied, S.A. Anti-neoplastic activities of sepia officinalis ink and Coelatura aegyptiaca extracts against Ehrlich ascites carcinoma in Swiss albino mice. Int. J. Clin. Exp. Pathol., 2015, 8(4), 3543.
[63]
Kathiriya, A.; Das, K.; Kumar, E.; Mathai, K. Evaluation of antitumor and antioxidant activity of Oxalis corniculata linn. against ehrlich ascites carcinoma on mice. Iran. J. Cancer Prev., 2010, 3(4), 157-165.
[64]
Stanojevic, L.P.; Marjanovic-Balaban, Z.R.; Kalaba, V.D.; Stanojevic, J.S.; Cvetkovic, D.J. Chemical composition, antioxidant and antimicrobial activity of chamomile flowers essential oil (Matricaria chamomilla L.). J. Essent. Oil Bear. Pl., 2016, 19(8), 2017-2028.
[65]
Srivastava, J.K.; Shankar, E.; Gupta, S. Chamomile: A herbal medicine of the past with a bright future. Mol. Med. Rep., 2010, 3(6), 895-901.
[66]
Sharafzadeh, S.; Alizadeh, O. German and Roman chamomile. J.
Appl. Pharm. Sci, 2011, 1(10), 01-05.
[67]
Greenstein, J.P. The in vivo effect on liver catalase by a tumor1. J.
Natl. Cancer Inst., 1955, 15(Supplement_5)1603-1605
[68]
Yamaguchi, Y.; Sato, K.; Endo, H. Depression of catalase gene expression in the liver of tumor bearing nude mice. Biochem. Biophys. Res. Commun., 1992, 189(2), 1084-1089.
[69]
Xu, B.H.; Gupta, V.; Singh, S.V. Characterization of a human bladder cancer cell line selected for resistance to mitomycin C. Int. J. Cancer, 1994, 58(5), 686-692.
[70]
Arnér, E.S.; Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem., 2000, 267(20), 6102-6109.
[71]
Paz, M.M.; Zhang, X.; Lu, J.; Holmgren, A. A new mechanism of action for the anticancer drug mitomycin C: Mechanism-based inhibition of thioredoxin reductase. Chem. Res. Toxicol., 2012, 25(7), 1502-1511.
[72]
Constantinescu, A.; Pick, U.; Handelman, G.; Haramaki, N.; Han, D.; Podda, M.J.; Tritschler, H.; Packer, L. Reduction and transport of lipoic acid by human erythrocytes. Biochem. Pharmacol., 1995, 50(2), 253-261.
[73]
Okuda, J.; Hirai, Y.; Hayazaki, T. Mechanism of inhibition of erythrocyte glutathione reductase by Mitomycin-C. Clin. Chim. Acta, 1989, 181(1), 37-46.
[74]
Tur, L.; Bayşu Sözbilir, N. Effects of Matricaria chamomilla L. on lipid peroxidation, antioxidant enzyme systems, and key liver enzymes in CCl4-treated rats. Toxicol. Environ. Chem., 2012, 94(9), 1780-1788.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Current Cancer Therapy Reviews
Current Drug Safety
Current Drug Targets
Recent Patents on Anti-Cancer Drug Discovery
Letters in Drug Design & Discovery
Current Drug Discovery Technologies
Current Radiopharmaceuticals
Related Books
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Advances in Organic Synthesis
Frontiers in Natural Product Chemistry
Recent Advances in Analytical Techniques
Frontiers in Drug Design and Discovery
NEOPLASIA and FERTILITY
Therapeutic Use of Plant Secondary Metabolites
Frontiers in Computational Chemistry
Frontiers in Bioactive Compounds
Article Metrics
42
4